Global Hemostatic Agents Market

Global Hemostatic Agents Market Research Report 2021

Global Hemostatic Agents Market

Global Hemostatic Agents Market Research Report 2021


The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Hemostatic Agents Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Hemostatic Agents Market Overview:

Global Hemostatic Agents Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Hemostatic Agents involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Hemostatic Agents Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Hemostatic Agents market in 2020.

Global Hemostatic Agents Market Segmentation

By Type, Hemostatic Agents market has been segmented into:

Oxidized Regenerated Cellulose

Combination

Gelatin

Thrombin

Collagen

Others

By Application, Hemostatic Agents market has been segmented into:

Hospitals

Surgical Centers

Nursing Homes

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Hemostatic Agents market are:

Baxter International Incorporation

C.R. Bard Incorporation

B.Braun Melsungen AG

Integra Life Sciences Corporation

Equimedical

Marine Polymer Technologies

Gelita GmbH

Pfizer Inc

Advanced Medical Solutions Group

Vascular Solutions Inc

Z-Medica LLC

Mallinckrodt Plc

Covidien PLC.

Atrium Medical Corporation

Sanofi Group

Cryolife Inc.

Hemostasis LLC

Ethicon

The Medicines Company

Anika Therapeutics

Biom'Up SAS

BioCer Entwicklungs

1. Market Overview of Hemostatic Agents

1.1 Hemostatic Agents Market Overview

1.1.1 Hemostatic Agents Product Scope

1.1.2 Market Status and Outlook

1.2 Hemostatic Agents Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Hemostatic Agents Historic Market Size by Regions (2015-2020)

1.4 Hemostatic Agents Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Hemostatic Agents Sales Market by Type (2015-2026)

2.1 Global Hemostatic Agents Historic Market Size by Type (2015-2020)

2.2 Global Hemostatic Agents Forecasted Market Size by Type (2021-2026)

2.3 Oxidized Regenerated Cellulose

2.4 Combination

2.5 Gelatin

2.6 Thrombin

2.7 Collagen

2.8 Others

3. Covid-19 Impact Hemostatic Agents Sales Market by Application (2015-2026)

3.1 Global Hemostatic Agents Historic Market Size by Application (2015-2020)

3.2 Global Hemostatic Agents Forecasted Market Size by Application (2021-2026)

3.3 Hospitals

3.4 Surgical Centers

3.5 Nursing Homes

3.6 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Hemostatic Agents Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Hemostatic Agents Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Hemostatic Agents Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Hemostatic Agents Business

5.1 Baxter International Incorporation

5.1.1 Baxter International Incorporation Company Profile

5.1.2 Baxter International Incorporation Hemostatic Agents Product Specification

5.1.3 Baxter International Incorporation Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 C.R. Bard Incorporation

5.2.1 C.R. Bard Incorporation Company Profile

5.2.2 C.R. Bard Incorporation Hemostatic Agents Product Specification

5.2.3 C.R. Bard Incorporation Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 B.Braun Melsungen AG

5.3.1 B.Braun Melsungen AG Company Profile

5.3.2 B.Braun Melsungen AG Hemostatic Agents Product Specification

5.3.3 B.Braun Melsungen AG Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Integra Life Sciences Corporation

5.4.1 Integra Life Sciences Corporation Company Profile

5.4.2 Integra Life Sciences Corporation Hemostatic Agents Product Specification

5.4.3 Integra Life Sciences Corporation Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Equimedical

5.5.1 Equimedical Company Profile

5.5.2 Equimedical Hemostatic Agents Product Specification

5.5.3 Equimedical Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Marine Polymer Technologies

5.6.1 Marine Polymer Technologies Company Profile

5.6.2 Marine Polymer Technologies Hemostatic Agents Product Specification

5.6.3 Marine Polymer Technologies Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Gelita GmbH

5.7.1 Gelita GmbH Company Profile

5.7.2 Gelita GmbH Hemostatic Agents Product Specification

5.7.3 Gelita GmbH Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Pfizer Inc

5.8.1 Pfizer Inc Company Profile

5.8.2 Pfizer Inc Hemostatic Agents Product Specification

5.8.3 Pfizer Inc Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Advanced Medical Solutions Group

5.9.1 Advanced Medical Solutions Group Company Profile

5.9.2 Advanced Medical Solutions Group Hemostatic Agents Product Specification

5.9.3 Advanced Medical Solutions Group Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Vascular Solutions Inc

5.10.1 Vascular Solutions Inc Company Profile

5.10.2 Vascular Solutions Inc Hemostatic Agents Product Specification

5.10.3 Vascular Solutions Inc Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Z-Medica LLC

5.11.1 Z-Medica LLC Company Profile

5.11.2 Z-Medica LLC Hemostatic Agents Product Specification

5.11.3 Z-Medica LLC Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Mallinckrodt Plc

5.12.1 Mallinckrodt Plc Company Profile

5.12.2 Mallinckrodt Plc Hemostatic Agents Product Specification

5.12.3 Mallinckrodt Plc Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Covidien PLC.

5.13.1 Covidien PLC. Company Profile

5.13.2 Covidien PLC. Hemostatic Agents Product Specification

5.13.3 Covidien PLC. Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Atrium Medical Corporation

5.14.1 Atrium Medical Corporation Company Profile

5.14.2 Atrium Medical Corporation Hemostatic Agents Product Specification

5.14.3 Atrium Medical Corporation Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Sanofi Group

5.15.1 Sanofi Group Company Profile

5.15.2 Sanofi Group Hemostatic Agents Product Specification

5.15.3 Sanofi Group Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.16 Cryolife Inc.

5.16.1 Cryolife Inc. Company Profile

5.16.2 Cryolife Inc. Hemostatic Agents Product Specification

5.16.3 Cryolife Inc. Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.17 Hemostasis LLC

5.17.1 Hemostasis LLC Company Profile

5.17.2 Hemostasis LLC Hemostatic Agents Product Specification

5.17.3 Hemostasis LLC Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.18 Ethicon

5.18.1 Ethicon Company Profile

5.18.2 Ethicon Hemostatic Agents Product Specification

5.18.3 Ethicon Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.19 The Medicines Company

5.19.1 The Medicines Company Company Profile

5.19.2 The Medicines Company Hemostatic Agents Product Specification

5.19.3 The Medicines Company Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.20 Anika Therapeutics

5.20.1 Anika Therapeutics Company Profile

5.20.2 Anika Therapeutics Hemostatic Agents Product Specification

5.20.3 Anika Therapeutics Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.21 Biom'Up SAS

5.21.1 Biom'Up SAS Company Profile

5.21.2 Biom'Up SAS Hemostatic Agents Product Specification

5.21.3 Biom'Up SAS Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.22 BioCer Entwicklungs

5.22.1 BioCer Entwicklungs Company Profile

5.22.2 BioCer Entwicklungs Hemostatic Agents Product Specification

5.22.3 BioCer Entwicklungs Hemostatic Agents Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Hemostatic Agents Market Size (2015-2026)

6.2 North America Hemostatic Agents Key Players in North America (2015-2020)

6.3 North America Hemostatic Agents Market Size by Type (2015-2020)

6.4 North America Hemostatic Agents Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Hemostatic Agents Market Size (2015-2026)

7.2 East Asia Hemostatic Agents Key Players in North America (2015-2020)

7.3 East Asia Hemostatic Agents Market Size by Type (2015-2020)

7.4 East Asia Hemostatic Agents Market Size by Application (2015-2020)

8. Europe

8.1 Europe Hemostatic Agents Market Size (2015-2026)

8.2 Europe Hemostatic Agents Key Players in North America (2015-2020)

8.3 Europe Hemostatic Agents Market Size by Type (2015-2020)

8.4 Europe Hemostatic Agents Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Hemostatic Agents Market Size (2015-2026)

9.2 South Asia Hemostatic Agents Key Players in North America (2015-2020)

9.3 South Asia Hemostatic Agents Market Size by Type (2015-2020)

9.4 South Asia Hemostatic Agents Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Hemostatic Agents Market Size (2015-2026)

10.2 Southeast Asia Hemostatic Agents Key Players in North America (2015-2020)

10.3 Southeast Asia Hemostatic Agents Market Size by Type (2015-2020)

10.4 Southeast Asia Hemostatic Agents Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Hemostatic Agents Market Size (2015-2026)

11.2 Middle East Hemostatic Agents Key Players in North America (2015-2020)

11.3 Middle East Hemostatic Agents Market Size by Type (2015-2020)

11.4 Middle East Hemostatic Agents Market Size by Application (2015-2020)

12. Africa

12.1 Africa Hemostatic Agents Market Size (2015-2026)

12.2 Africa Hemostatic Agents Key Players in North America (2015-2020)

12.3 Africa Hemostatic Agents Market Size by Type (2015-2020)

12.4 Africa Hemostatic Agents Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Hemostatic Agents Market Size (2015-2026)

13.2 Oceania Hemostatic Agents Key Players in North America (2015-2020)

13.3 Oceania Hemostatic Agents Market Size by Type (2015-2020)

13.4 Oceania Hemostatic Agents Market Size by Application (2015-2020)

14. South America

14.1 South America Hemostatic Agents Market Size (2015-2026)

14.2 South America Hemostatic Agents Key Players in North America (2015-2020)

14.3 South America Hemostatic Agents Market Size by Type (2015-2020)

14.4 South America Hemostatic Agents Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Hemostatic Agents Market Size (2015-2026)

15.2 Rest of the World Hemostatic Agents Key Players in North America (2015-2020)

15.3 Rest of the World Hemostatic Agents Market Size by Type (2015-2020)

15.4 Rest of the World Hemostatic Agents Market Size by Application (2015-2020)

16 Hemostatic Agents Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Hemostatic Agents Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Hemostatic Agents Market?
Some of the finest and top-notch companies pioneering the Hemostatic Agents Market are Baxter International Incorporation, C.R. Bard Incorporation, B.Braun Melsungen AG, Integra Life Sciences Corporation, Equimedical, Marine Polymer Technologies, Gelita GmbH, Pfizer Inc, Advanced Medical Solutions Group, Vascular Solutions Inc, Z-Medica LLC, Mallinckrodt Plc, Covidien PLC., Atrium Medical Corporation, Sanofi Group, Cryolife Inc., Hemostasis LLC, Ethicon, The Medicines Company, Anika Therapeutics, Biom'Up SAS, BioCer Entwicklungs.
How are the major players in the Hemostatic Agents Market planning to grow in the future?
A large number of Global Hemostatic Agents players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.
What important business segments are segregated by application types in the latest edition of the Hemostatic Agents Market?
The key business segments in the Hemostatic Agents Market are segregated by applications [Hospitals, Surgical Centers, Nursing Homes, Others] and types [Oxidized Regenerated Cellulose, Combination, Gelatin, Thrombin, Collagen, Others].
What is the market value of the Hemostatic Agents Industry?
In 2024, the Hemostatic Agents Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What challenges does the Hemostatic Agents Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Hemostatic Agents Market across the extensive corporate landscape.
What makes the latest Hemostatic Agents Market study unique?
The latest version of the Hemostatic Agents Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.